• About
    • About
    • Leadership
  • Science
    • Product
    • Pipeline
    • Publications
    • Clinical Trials
  • News
  • Careers
  • Contact
Restoring balance to the immune system
  • About
    • About
    • Leadership
  • Science
    • Product
    • Pipeline
    • Publications
    • Clinical Trials
  • News
  • Careers
  • Contact

Archives

Monthly Archive for: "September, 2021"
By PG
In News
Posted September 28, 2021

Sentien Reports on Data from First Ph I/II Study of SBI-101 in Subjects with AKI in STEM CELLS Translational Medicine

Read More
By PG
In News
Posted September 21, 2021

Sentien Biotechnologies Receives Award from Maryland Stem Cell Research Fund to Support Clinical Study of SBI-101

Read More
By PG
In Press Releases
Posted September 2, 2021

Sentien Biotechnologies Partners with BARDA to Evaluate High Dose Cohort in Phase 1/2 Trial of SBI-101 for Treatment of Acute Kidney Injury Associated with Sepsis

LEXINGTON, MA – Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced a partnership with the Biomedical Advanced [...]

Read More
Sentien Biotechnologies, Inc.
99 Hayden Avenue
Building E, Suite 140
Lexington, MA 02421

+1-781-361-9031
info@sentienbiotech.com
Connect With Us
Home About About Leadership Boards Science Product Pipeline Publications Clinical Trials
News Careers Contact
Copyright © Privacy Policy Terms of Use Site Design: Monderer Design